Current treatment of atypical hemolytic uremic syndrome

Tremendous advances have been made in understanding the pathogenesis of atypical Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular biology of aHUS resulted in rapid advances in treatment with eculizumab (Soliris(®), Alexion Pharmaceuticals Inc.). Historically,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kaplan, Bernard S., Ruebner, Rebecca L., Spinale, Joann M., Copelovitch, Lawrence
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2014
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204535/
https://ncbi.nlm.nih.gov/pubmed/25343125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2014.01001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk